The selection of an enteral formula must be patient specific. The functioning and capacity of the GI tract, underlying disease states and patient tolerance must be assessed to determine which formula should be selected. In terms of revenue, the Global Enteral Feeding Formulas Market was US$ 4680 Mn in 2020 and is estimated to be US$ h Mn by 2030. Nutritional support is considered as a vital component in medical care. Enteral nutrition (EN) is provision of nutrients via the gastrointestinal (GI) tract through a feeding tube, catheter or stoma. It is the preferred route for the provision of nutrition for patients who cannot meet their nutrition needs through voluntary oral intake. This type of feeding provides many physiologic, metabolic, safety, and cost benefits over other methods of feeding. Enteral nutrition is preferred as a route of administration for nutritional support when gastrointestinal tract is functional. Compared to the conventional central venous feeding, enteral feeding is associated with fewer serious complications. It helps in better nutrient absorption and facilitates better metabolic activities.

Top Players of Global Enteral Feeding Formulas Market are Studied: NUTRICIA, Mead Johnson & Company, LLC, Danone S.A., B. Braun Melsungen AG, Global Health Products, Inc., Victus, Inc., Meiji Holdings Co., Ltd, Hormel Foods, LLC, Byram Healthcare, Medline Industries Inc, Abbott Laboratories, Fresenius Kabi A, Nutritional Medicinals, LLC, HOIL BIOMAED INC., Real Food Blends, Nestlé S.A. amongst others

Click to view the full report:

Enteral Feeding Formulas Market, by Stage

At present, the adult sub segment is leading the market. Enteral nutrition in adults is prescribed when an individual is not capable for oral intake of food. For instance, in dysphagia or reduced level of consciousness, oral intake is not adequate to meet nutritional requirements in adults. At that time, enteral nutrition has proved to be safe, cost effective, and compatible with the body’s normal processes. Enteral feeding formulas are used in adults suffering from various health related conditions. They are used for patients suffering from severe acute pancreatitis, high output proximal fistula, intractable vomiting or diarrhea and others. Many a times due to major injuries, individuals get bedridden. Even if an individual undergoes major surgeries of throat and stomach lining, he is not allowed to consume food orally. At, such times eternal feeding formulas are prescribed by doctors.

Enteral Feeding Formulas Market, by Region

The region of North America is on the forefront as compared to others during the forecast year 2021-2030, owing to increasing number of citizens residing in the United States, suffering from severe esophagus related conditions and widespread awareness about enteral feeding devices. The American Cancer Society estimated that people suffering from esophageal cancer in the United States for the year 2018 is 17,290. The number has been increasing since 2010. The affected people are mostly advised to opt for enteral feeding as their digestion system remains weak which restricts them from taking anything orally.

Report objectives:

  • To characterize, depict, section, and conjecture the catchphrase market by type, application and locale
  • To analyze each submarket in terms of its own growth trends, prospects and contribution to the overall market.
  • To provide detailed information about the major factors influencing the growth of the market such as drivers, restraints, opportunities, and challenges.
  • To profile the key market players, generate a comparative analysis based on their business overviews, service offerings, regional presence, business strategies and provide companies in-house statistical tools required to understand the competitive landscape


Contact Us:

Company: Absolute Markets Insights

Email Id:

Phone: IN +917400242424, US +1-510-420-1213

Contact Name: Shreyas Tanna